Literature DB >> 12043786

Influence of extracorporeal shock-wave application on normal bone in an animal model in vivo. Scintigraphy, MRI and histopathology.

M Maier1, S Milz, T Tischer, W Münzing, N Manthey, A Stäbler, N Holzknecht, C Weiler, A Nerlich, H J Refior, C Schmitz.   

Abstract

There is little information about the effects of extracorporeal shock-wave application (ESWA) on normal bone physiology. We have therefore investigated the effects of ESWA on intact distal rabbit femora in vivo. The animals received 1500 shock-wave pulses each of different energy flux densities (EFD) on either the left or right femur or remained untreated. The effects were studied by bone scintigraphy, MRI and histopathological examination. Ten days after ESWA (0.5 mJ/mm2 and 0.9 mJ/mm2 EFD), local blood flow and bone metabolism were decreased, but were increased 28 days after ESWA (0.9 mJ/mm2). One day after ESWA with 0.9 mJ/mm2 EFD but not with 0.5 mJ/mm2, there were signs of soft-tissue oedema, epiperiosteal fluid and bone-marrow oedema on MRI. In addition, deposits of haemosiderin were found epiperiosteally and within the marrow cavity ten days after ESWA. We conclude that ESWA with both 0.5 mJ/mm2 and 0.9 mJ/mm2 EFD affected the normal bone physiology in the distal rabbit femur. Considerable damaging side-effects were observed with 0.9 mJ/mm2 EFD on periosteal soft tissue and tissue within the bone-marrow cavity.

Entities:  

Mesh:

Year:  2002        PMID: 12043786     DOI: 10.1302/0301-620x.84b4.11621

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  9 in total

Review 1.  In-vehicle extremity injuries from improvised explosive devices: current and future foci.

Authors:  Arul Ramasamy; Spyros D Masouros; Nicolas Newell; Adam M Hill; William G Proud; Katherine A Brown; Anthony M J Bull; Jon C Clasper
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-27       Impact factor: 6.237

2.  [Extracorporal shock wave therapy for the treatment of pseudarthrosis : New experiences with an old technology].

Authors:  J Everding; M Freistühler; J Stolberg-Stolberg; M J Raschke; P Garcia
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

3.  Predictive role of scintigraphy (BS) in bone union induction using extracorporeal shock wave treatment (ESWT).

Authors:  Monika Czarnowska-Cubała; Katarzyna Gwoździewicz; Michał Studniarek; Jerzy Lasek
Journal:  J Orthop       Date:  2013-05-29

4.  [New bone formation by extracorporeal shock waves. Dependence of induction on energy flux density].

Authors:  M Maier; J Hausdorf; T Tischer; S Milz; C Weiler; H J Refior; C Schmitz
Journal:  Orthopade       Date:  2004-12       Impact factor: 1.087

Review 5.  The Effects of the Exposure of Musculoskeletal Tissue to Extracorporeal Shock Waves.

Authors:  Tobias Wuerfel; Christoph Schmitz; Leon L J Jokinen
Journal:  Biomedicines       Date:  2022-05-06

6.  Low-energy extracorporeal shockwave therapy (ESWT) improves metaphyseal fracture healing in an osteoporotic rat model.

Authors:  Gina A Mackert; Matthias Schulte; Christoph Hirche; Dimitra Kotsougiani; Julian Vogelpohl; Bernd Hoener; Teresa Fiebig; Stefanie Kirschner; Marc A Brockmann; Marcus Lehnhardt; Ulrich Kneser; Leila Harhaus
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

7.  Ultrasonography and clinical outcome comparison of extracorporeal shock wave therapy and corticosteroid injections for chronic plantar fasciitis: A randomized controlled trial.

Authors:  Ta-Wei Lai; Hsiao-Li Ma; Meng-Shiunn Lee; Po-Ming Chen; Ming-Chou Ku
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-03-01       Impact factor: 2.041

8.  Extracorporeal shockwave therapy: A systematic review of its use in fracture management.

Authors:  Ba Petrisor; Selene Lisson; Sheila Sprague
Journal:  Indian J Orthop       Date:  2009-04       Impact factor: 1.251

9.  Extracorporeal shock-wave therapy in the treatment of pseudoarthrosis: a case report.

Authors:  Stefan Endres; Markus Weiskirch; Christiane Hinz; Felix Hütter; Axel Wilke
Journal:  Cases J       Date:  2008-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.